Annual Report 2025–2026
Accountability, transparency, and the measurable impact of evidence-based medicine advancement.
501(c)(3) Nonprofit Organization
EIN: 92-2997844
Tax-exempt under IRC § 501(c)(3). Contributions are tax-deductible to the extent permitted by law.
Annual information return (Form 990) filed with the IRS. Available on request.
Mission
Mission
The American Society of Hirudotherapy advances evidence-based, protocolized use of FDA-cleared medicinal leech therapy in the United States — through rigorous research synthesis, clinical infrastructure development, and transparent education for both healthcare professionals and the public.
Evidence Synthesis
Curating and publishing the most comprehensive English-language evidence base for hirudotherapy, grounded in peer-reviewed literature.
Clinical Standards
Developing safety protocols, infection-control guidelines, and standardized clinical workflows for practitioners.
Education
Providing healthcare professionals and the public with accurate, regulatory-aligned information about FDA-cleared leech therapy.
Transparency
Operating as an open, accountable nonprofit with documented governance, conflict-of-interest policies, and publicly available financial records.
Vision
Vision
A United States healthcare system in which FDA-cleared medicinal leech therapy is understood, safely practiced, and appropriately integrated into evidence-based clinical care — with every practitioner and patient supported by accurate, accessible information.
Establish the definitive English-language clinical reference for hirudotherapy by 2027
Support the formation of U.S. training and certification standards
Build a verified network of 50+ credentialed practitioners
Publish 5 original systematic reviews or meta-analyses
Achieve broad recognition as the authoritative U.S. nonprofit for hirudotherapy
Achievements 2025–2026
Key milestones in our first operational year.
Digital Infrastructure
Launched hirudotherapysociety.org
Built and deployed a 134-page evidence-based website covering clinical conditions, leech biology, pharmacology, safety protocols, and regulatory frameworks — the most comprehensive English-language resource of its kind.
Research Library
Hirudopedia Evidence Database
Curated and published a structured literature library indexing 50+ peer-reviewed publications on hirudotherapy, with annotation by condition, evidence grade, and study design.
International Reach
Three-Language Platform
Launched full translations in English, Russian, and Spanish — making the evidence base accessible to practitioners and patients across three major language communities.
Safety Standards
Safety Protocol Library
Published comprehensive Aeromonas management protocols, infection-control guidelines, and post-treatment care standards aligned with current evidence.
Governance
Board of Directors Established
Formed the founding Board of Directors with clinical, administrative, and operations expertise. Adopted conflict-of-interest policy, editorial standards, and donor rights policy.
Clinical Evidence
FDA Regulatory Documentation
Published authoritative documentation of the FDA 510(k) clearance history for medicinal leeches, including K040187, K132958, K140907 — correcting widespread misclassifications in the field.
Impact Metrics
Measuring the reach and effectiveness of our work.
134+
Evidence-based pages published
50+
Peer-reviewed publications indexed
3
Languages supported
1,200+
Indexed URLs in sitemap
5
Core safety protocols published
3
FDA 510(k) clearances documented
Financial Transparency
We are committed to full financial transparency as a 501(c)(3) organization.
Audited Financial Statements
The Society was incorporated in 2023 and completed its first full fiscal year in 2025. Audited financial statements and Form 990 for fiscal year 2025 will be available in Q4 2026. In the interim, unaudited financials and the IRS determination letter are available on request.
To request financial documents, contact us at adokukin@leechmedicine.com.
Nonprofit Status
Incorporated as a 501(c)(3) public charity. EIN: 92-2997844. Tax-deductible donations accepted.
Conflict of Interest Policy
All board members and content contributors complete annual conflict-of-interest disclosures. Material conflicts result in recusal.
Donor Privacy
Donor information is never sold, traded, or shared with third parties outside of legal requirements.
Gift Acceptance Policy
Gifts that create conflicts of interest, impose conditions contrary to our mission, or carry unacceptable reputational risk are declined.
Board of Directors
The governing body responsible for organizational oversight, mission fidelity, and fiduciary accountability.
Related Resources
Support Our Mission
Tax-deductible gifts advance research, education, and safety standards for FDA-cleared hirudotherapy.
Learn more →
Board of Directors
Meet the team guiding the Society's mission, governance, and clinical standards.
Learn more →
About the Society
Learn about our history, mission, values, and organizational structure.
Learn more →